Trim 15–25% of MO at $67.30–67.50; Underweight rating rejecting Hold and Sell as both magnitude-overshoot vs. documented structural floor
Underweight rating reflects rejection of both passive Hold (prohibited by 9/28 binding reflection) and magnitude-overshoot Sell (structural floor at 200 SMA $65.30 is genuine). The 15–25% trim captures directional asymmetry without surrendering the 6.59% dividend carry the structural floor defends. MO can drop 10–15% while paying dividend; yield is a total-return floor, not a price floor. The trim is sized to absorb one adverse catalyst (NJOY PMTA rejection, Q3 FCF disappointment) without overshooting into carry. Hard stop $66.32 daily close with volume >9M = full exit of residual. Tactical short (if used) sized ≤2% portfolio, stop $70.10.
| Position | Action |
|---|---|
| First tranche at current levels | Trim 10–15% at $67.30–$67.50 |
| Confirmed close < $67.00 on volume >5M OR retest of $70.40 with volume >12M showing distribution/rejection | Execute second tranche 5–10% |
| Daily close below $66.32 with volume >9M | Full exit of residual position |
| MO closes below prior 10-day low against SPY (per 9/10 binding lesson) | Trigger additional 10% trim |
| Tactical short position | Size ≤2% of portfolio, stop $70.10, targeting $65.30 initially, then $63.50 on structural break |
| Re-entry criteria | Confirmed close > $70.40 on volume >12M with RSI >55, capped at 25% of residual |
| Cancel pending trim | Reclaim $68.60 on close |
MO is a $111.79 billion cash-flow fortress that returned $7.06 billion to shareholders in dividends last year, sits in a golden-cross regime with a 200 SMA rising from $61 to $65 over six months, and is being completely mispriced by bears who are still fighting the structural-decline narrative from a decade ago.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $68.58 | bearish |
| 50 SMA | $67.81 | bearish |
| 200 SMA | $65.30 | bullish |
| RSI (14) | 43.64 | bearish |
| MACD Line | +0.243 | bearish |
| MACD Signal Line | +0.376 | bearish |
| MACD Histogram | –0.13 | bearish |
| Bollinger Upper Band (20) | $70.43 | neutral |
| Bollinger Middle Band (20) | $68.59 | neutral |
| Bollinger Lower Band (20) | $66.75 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: MO closes below prior 10-day low against SPY
Then: Trigger additional 10% trim
EV: +5.7% · concedes: FDA menthol regulation risk is real but has been priced in for 15 years; NJOY $1.26B Q4 2025 impairment was a non-cash goodwill write-down, not operational failure; PEG of 2.58 makes traditional growth metrics look unfavorable but is irrelevant for tobacco FCF model; Sentiment is currently low with no buzz around MO
MO is a high-yield value trap trading on fumes — a structurally declining business priced for perfection that just printed a fresh MACD sell signal, sits below three momentum indicators, and relies on a $1.28× dividend coverage ratio that leaves zero margin for error in any earnings disappointment. The 6.59% yield isn't a gift — it's the market telling you this is a risky asset.
EV: -$65.30 (200 SMA test on close below $66.75) · concedes: ZYN is winning the nicotine pouch category and Philip Morris is better positioned to acquire premium pouch brands; The 50+ year dividend streak is a real moat in traditional tobacco; AI/tech pair trade thesis depends on tech names being fundamentally sound, not just long-duration; Better yield alternatives exist: utilities with regulated growth, energy MLPs, BDCs
→ vs conservative: 200 SMA at $65.30 is lagging indicator; buying at $67.81 near 50 SMA with three momentum indicators flashing red is falling knife, not disciplined dip-buying
→ vs neutral: Macro thesis (97% no rate cuts, 8% recession, defensive yield demand) already fully priced in; MO breaking 10 EMA on distribution days proves the tailwind has been absorbed
→ vs conservative: Earnings growth from $4.75 to $5.86 is base effect rebound from NJOY impairment, not genuine operating momentum; PEG of 2.58 shows consensus too optimistic
→ vs neutral: Structural volume decline and accelerating 4-5% annual combustible volume drops approaching pricing power ceiling; distribution at 7.57M shares at $67.80 is institutional repositioning, not random noise
| ATR (14) | $1.36 | neutral |
| Latest Close (2026-09-30) | $67.34 | neutral |
Support: 67.81 · 66.75 · 65.3 | Resistance: 70.1 · 70.43 · 71.5
MO is trading at $67.34 (Sept 30 close), having pulled back from a Sept 16 high of $70.10 after a +7.9% rally from $64.99 on Aug 19. The structural uptrend is intact (price +$2.04 above 200 SMA at $65.30, golden cross regime confirmed), but short-term momentum has deteriorated with price below the 10 EMA ($68.58), RSI at 43.64 (down from 61.41 on Sept 16), and MACD crossing below its signal line on Sept 30 with histogram turning negative (–0.13). Volatility is compressed: ATR has fallen to $1.36 from $2.05 in August (~34% contraction), and Bollinger bandwidth is narrow at $3.68 (~5.4% of mid). Key battleground is the $67.80 zone (50 SMA); a sustained close below $66.75 (lower Bollinger band) would confirm a bearish regime change and test the 200 SMA. HOLD is the base recommendation with tactical buy-trigger at $67.80 reclaim and stop below $66.75; downgrade to SELL warranted on decisive close below $66.75.
Market Cap
$111.79B
P/E Ratio (TTM)
14.09×
Forward P/E
11.42×
PEG Ratio
2.58
Price/Book
-41.90×
EPS (TTM)
$4.75
Forward EPS
$5.86
52-Week High
$77.06
52-Week Low
$54.70
50-Day Moving Average
$68.63
200-Day Moving Average
$67.28
Beta
0.494
Dividend Yield
6.59%
Gross Profit
$17.79B
EBITDA
$15.77B
Operating Margin
76.36%
Net Profit Margin
38.99%
Return on Assets (ROA)
29.54%
Q2 2026 Operating Revenue
$6.105B
Q2 2026 Net Income
$2.298B
Q2 2026 Diluted EPS
$1.37
Q1 2026 Operating Revenue
$5.427B
Q1 2026 Net Income
$2.183B
Q1 2026 Diluted EPS
$1.30
Q3 2025 Net Income
$2.375B
Q3 2025 Diluted EPS
$1.41
Q2 2025 Net Income
$2.378B
Q2 2025 Diluted EPS
$1.41
Q1 2025 Diluted EPS
$0.63
Q4 2025 Net Income
$1.117B
Q4 2025 Impairment Charge
$1.26B
Total Debt
$24.58B
Cash & Equivalents
$2.37B
Net Debt
$22.21B
Total Equity
-$2.67B
Net Tangible Assets
-$20.3B
Current Ratio
0.518
Working Capital
-$3.75B
Available-for-Sale Securities
$8.90B
Investments & Advances
$8.90B
Goodwill & Intangibles
$17.64B
TTM Free Cash Flow
$9.03B
TTM Operating Cash Flow
~$9.34B
TTM CapEx
~$0.30B
TTM Dividends Paid
~$7.06B
TTM Share Buybacks
~$0.79B
TTM Net Income
$7.95B
Cumulative Treasury Stock
$43.5B
Strengths
Concerns
Altria Group (MO) presents as a financially robust, high-yielding defensive name trading at reasonable valuation with a Forward P/E of 11.4×, backed by an elite moat in U.S. tobacco with 76%+ operating margins and demonstrated pricing power. The 6.59% dividend is sustainably covered by ~$9.03B in TTM FCF with a ~78% payout ratio, while the $8.9B AB InBev stake represents hidden asset optionality. Structural headwinds including secular cigarette volume declines (~4-5% annually), regulatory risks, litigation exposure, and $17.64B in goodwill/intangibles at impairment risk create ongoing concerns best suited for income-focused, total-return mandates.
Macro: Fed policy is aggressively hawkish: Polymarket implies 97% probability of no rate cuts in 2026 ($8.7M volume), with Fed officials signaling inflation remains too high. The 10-year Treasury yield has touched its highest level since 2002, creating a multi-decade high in the risk-free benchmark that pressures long-duration assets while benefiting short-duration income assets. US recession probability stands at just 8% by end-2026 (down 2pp week-over-week), indicating consumer spending should remain intact. Equity markets are rotating into tech/AI leadership (IBM, Accenture, Micron, Google, Synopsys), bypassing defensive sectors like tobacco.